Article info

Short report
The International Fragile X Premutation Registry: building a resource for research and clinical trial readiness

Authors

  1. Correspondence to Dr David Hessl, Department of Psychiatry and Behavioral Sciences, University of California Davis School of Medicine, Sacramento, USA; drhessl{at}ucdavis.edu
View Full Text

Citation

Hessl D, Rosselot H, Miller R, et al
The International Fragile X Premutation Registry: building a resource for research and clinical trial readiness

Publication history

  • Received March 9, 2022
  • Accepted May 23, 2022
  • First published June 14, 2022.
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.